Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Peginterferon alfa-2a + Ribavirin in HIV/HCV Genotype 1/4 Coinfection
2004-004948-45Phase 4Active
- Sponsor
- San Cecilio University Hospital
- Start
- May 2006
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of interferon alfa and ribavirin in hepatitis C virus infection and human immunodeficiency virus infection (HIV) (2 arms), sponsored by San Cecilio University Hospital. Started May 2006; status: active.
02
Drugs
interferon alfaribavirin
03
Conditions
hepatitis C virus infectionhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-004948-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004948-45.